v3.26.1
Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Preferred  Stock
Additional Paid-in Capital
Retained Earnings/(Deficit)
Beginning balance (in shares) at Dec. 31, 2024   29,640      
Beginning balance at Dec. 31, 2024 $ 543,423 $ 296 $ 220,472 $ 824,380 $ (501,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Grant of restricted stock and amortization of equity based compensation (in shares)   51      
Grant of restricted stock and amortization of equity based compensation, net 384 $ 1   383  
Common dividends declared (12,167)       (12,167)
Preferred dividends declared [1] (10,655)       (10,655)
Net Income/(Loss) 15,422       15,422
Ending balance (in shares) at Jun. 30, 2025   29,691      
Ending balance at Jun. 30, 2025 536,407 $ 297 220,472 824,763 (509,125)
Beginning balance (in shares) at Mar. 31, 2025   29,659      
Beginning balance at Mar. 31, 2025 543,870 $ 297 220,472 824,587 (501,486)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Grant of restricted stock and amortization of equity based compensation (in shares)   32      
Grant of restricted stock and amortization of equity based compensation, net 176     176  
Common dividends declared (6,235)       (6,235)
Preferred dividends declared [2] (5,349)       (5,349)
Net Income/(Loss) 3,945       3,945
Ending balance (in shares) at Jun. 30, 2025   29,691      
Ending balance at Jun. 30, 2025 $ 536,407 $ 297 220,472 824,763 (509,125)
Beginning balance (in shares) at Dec. 31, 2025 31,744 31,744      
Beginning balance at Dec. 31, 2025 $ 560,734 $ 317 220,472 840,401 (500,456)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Grant of restricted stock and amortization of equity based compensation (in shares) [3]   59      
Grant of restricted stock and amortization of equity based compensation, net [3] 172 $ 1   171  
Common dividends declared (15,250)       (15,250)
Preferred dividends declared [1] (10,359)       (10,359)
Net Income/(Loss) $ 10,707       10,707
Ending balance (in shares) at Jun. 30, 2026 31,803 31,803      
Ending balance at Jun. 30, 2026 $ 546,004 $ 318 220,472 840,572 (515,358)
Beginning balance (in shares) at Mar. 31, 2026   31,735      
Beginning balance at Mar. 31, 2026 544,396 $ 317 220,472 840,396 (516,789)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Grant of restricted stock and amortization of equity based compensation (in shares)   68      
Grant of restricted stock and amortization of equity based compensation, net 177 $ 1   176  
Common dividends declared (7,633)       (7,633)
Preferred dividends declared [2] (5,205)       (5,205)
Net Income/(Loss) $ 14,269       14,269
Ending balance (in shares) at Jun. 30, 2026 31,803 31,803      
Ending balance at Jun. 30, 2026 $ 546,004 $ 318 $ 220,472 $ 840,572 $ (515,358)
[1] For the six months ended June 30, 2026 and 2025, dividends totaling $1.03126 and $1.03126 per share of Series A Preferred Stock, $1.00 and $1.00 per share of Series B Preferred Stock, and $1.318343 and $1.397926 per share of Series C Preferred Stock outstanding were declared, respectively
[2] For the three months ended June 30, 2026 and 2025, dividends totaling $0.51563 and $0.51563 per share of Series A Preferred Stock, $0.50 and $0.50 per share of Series B Preferred Stock, and $0.665952 and $0.704864 per share of Series C Preferred Stock outstanding were declared, respectively.
[3] During the six months ended June 30, 2026, the Company retired 19 thousand shares of common stock to pay $0.2 million of withholding taxes on the net settlement of equity based compensation.